Latest Mergers And Acquisitions News

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project and raised $2.5 million in firm commitments, positioning itself for significant exploration activity in Western Australia and Sweden.

Kairos Minerals has completed a $27 million placement and secured a landmark mineral rights agreement with Pilbara Minerals, significantly expanding its Mt York Gold Project drilling program and advancing exploration at Roe Hills.

Steadfast Group Limited has posted a 17.2% rise in underlying net profit after tax for FY25, marking its 12th consecutive year of growth, even as its CEO steps aside pending an investigation. The company also announced a leadership transition with Vicki Allen named incoming Chair.

Micro-X Ltd has secured its largest-ever $3.3 million Rover Plus order from Malaysia’s Ministry of Health and is progressing critical Head CT imaging trials, supported by a $4.4 million government grant.

PhosCo Ltd reports breakthrough drilling results at its Gasaat Phosphate Project in Tunisia, securing a €1M grant from EBRD and a $1.1M investment from its Managing Director, setting the stage for a pivotal feasibility study.

Victory Metals has significantly upgraded its North Stanmore rare earths resource, reporting record dysprosium grades and producing a high-purity rare earth oxide. The company also secured strategic partnerships and $11.5 million in new funding.

Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.

Po Valley Energy reported consistent gas production and strong cash flow in Q3 2025, while advancing development plans and a new gas sales agreement in Italy.

Enlitic, Inc. reported a strong quarter with record cash receipts and contract wins, yet withdrew its revenue guidance due to delayed project completions. The company remains confident in reaching operational cash flow break-even by the end of Q4 FY25.

Artrya Limited has completed the second tranche of its share placement, raising $14.7 million to advance its AI-powered Salix platform for coronary artery disease detection.

Central Petroleum reported a slight dip in sales volumes and revenue for the September quarter, offset by a significant reserves upgrade and a new long-term gas supply agreement that promises cash flow stability.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.